TEST BANK FOR RAUS RESPIRATORY CARE
n1 n1 n1 n1 n1
PHARMACOLOGY11th EDITION BY GARDENHIRE/ALL
n1 1n n1 n1 n1
CHAPTERS S 1-23
n1 n1 n1
,CH 01: Introduction to Respiratory Care Pharmacology
n1 n1 n1 n1 n1 n1 n1
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th
n1 n1 n1 n1 n1 n1
Edition
n1
MULTIPLE RESPONSE n1
1. The listing of a drug and the amount of drug are found in which part of a prescription?
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature) n1
PRECISE ANSWER:-B n1
Reasoning :->>>The superscription directs the registered pharmacist to take the drug listed and preparethe
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
drug; the inscription lists the name and quantity of the drug being prescribed; the subscriptionprovides
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
directions to the registered pharmacist for preparing the drug; and the transcription, or signature, is the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
information the registered pharmacist writes on the label as instructions to the patient.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 7 n1
2. If generic substitution is permitted on a prescription:
n1 n1 n1 n1 n1 n1 n1
a. drug from only one manufacturer must be given.
n1 n1 n1 n1 n1 n1 n1
b. drug formulation may be changed by the registered pharmacist.
n1 n1 n1 n1 n1 n1 n1 n1
c. any manufactured brand of the drug listed may be given.
n1 n1 n1 n1 n1 n1 n1 n1 n1
d. drug strength may be changed by the registered pharmacist.
n1 n1 n1 n1 n1 n1 n1 n1
PRECISE ANSWER:-C n1
Reasoning :->>>A generic substitution allows any brand of a drug to be given, but the registered
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
pharmacist may not change a drug formulation without specific permission from the prescribing physician.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
A physician can indicate to the registered pharmacist that generic substitution is permitted in the filling of
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
the prescription. In such a case, the registered pharmacist may provide any manufacturer’s version of the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
prescribed drug, rather than a specific brand. However, the registered pharmacist may not change
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
thestrength of a drug without specific permission from the prescribing physician.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 8 n1
3. The study of drug, including their origin, properties, and interactions with living organisms, is known as
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
PRECISE ANSWER:-B n1
Reasoning:->>>Pharmacogenetics is the study of the interrelationship of genetic differences and drug effects. n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
Pharmacology is the study of drug (chemicals), including their origin, properties, and interactionswith living
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
organisms.
n1
Therapeutics is the art of treating illness with drug. Toxicology is the study of toxic substances and
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
theirpharmacologic actions, including antidotes and poison control.
n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 3 n1
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. chemical name. n1
b. generic name. c.official name. d.trade name. n1 n1 n1 n1 n1
PRECISE ANSWER:-D n1
Reasoning:->>>The chemical name indicates the drug’s chemical structure. The generic name is assignedby the n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
, United States
n1 n1
, Adopted Name Council and is usually based loosely on the drug’s chemical structure. The official name isthe
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
name given to the generic name once a drug becomes fully approved for general use and is admitted to the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
United States Pharmacopeia–National Formulary. The trade name is the brand, or proprietary, name given
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
by a particular manufacturer. For example, the generic drug albuterol is currently marketed by Schering-
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
n1 n1 n1
n1
n1 n1 n1 n1
REFERENCE: n 1 p. 5 n1
5. To find official information about drug (according to the FDA), you need to go to the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. Physician’s Desk Referenceerence (PDR). n1 n1 n1
b. Basic & Clinical Pharmacology. n1 n1 n1
c. United States Pharmacopeia–National Formulary (USP-NF).
n1 n1 n1 n1
d. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. n1 n1 n1 n1 n1 n1 n1
PRECISE ANSWER:-C n1
Reasoning:->>>Because the PDR is prepared by drug manufacturers themselves, it may be lacking in n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
objectivity. Basic & Clinical Pharmacology covers only general pharmacologic principles and drug classes.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
Goodman & Gilman’s The Pharmacological Basis of Therapeutics covers only general
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
pharmacologicprinciples and drug classes. The USP-NF is a book of standards containing information
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
about drugs, dietary supplements, and medical devices. The U.S. Food and Drug Administration
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
(FDA)considers this book the official standard for drug marketed in the United States.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 5 n1
6. Drug may be obtained from which of the following sources?
n1 n1 n1 n1 n1 n1 n1 n1 n1
a. Plants
b. Animals
c. Minerals
d. Plants, animals, and minerals n1 n1 n1
PRECISE ANSWER:-D n1
Reasoning:->>>Drug may be obtained from plants (e.g., digitalis), animals (e.g., insulin), and minerals(e.g., n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
magnesium sulfate).
n1 n1
REFERENCE: n 1 p. 5 n1
7. The branch of the U.S. government responsible for the process of approving drug for clinical use is the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. USAN Council. n1
b. FDA.
c. USP-NF.
d. PDR.
PRECISE ANSWER:-B n1
Reasoning:->>>The United States Adopted Name (USAN) Council is responsible for assigning a generic n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
name to a chemical that appears to have therapeutic use. The U.S. Food and Drug Administration (FDA) is
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
responsible for the process of approving drug for clinical use. The process by which a chemical movesfrom
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
the status of a promising potential drug to one fully approved by the FDA for general clinical use is,on
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
average, long, costly, and complex. Cost estimates vary, but in the 1980s it took an average of 13 to 15
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
yearsfrom chemical synthesis to marketing approval by the FDA, with a cost of $350 million in the United
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
States.
n1
The USP-NF is a book
n1 n1 n1 n1
of standards for drugs, dietary supplements, and medical devices. The PDR is a source of druginformation
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
prepared by drug manufacturers.
n1 n1 n1 n1
REFERENCE: n 1 p. 4 n1
n1 n1 n1 n1 n1
PHARMACOLOGY11th EDITION BY GARDENHIRE/ALL
n1 1n n1 n1 n1
CHAPTERS S 1-23
n1 n1 n1
,CH 01: Introduction to Respiratory Care Pharmacology
n1 n1 n1 n1 n1 n1 n1
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th
n1 n1 n1 n1 n1 n1
Edition
n1
MULTIPLE RESPONSE n1
1. The listing of a drug and the amount of drug are found in which part of a prescription?
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature) n1
PRECISE ANSWER:-B n1
Reasoning :->>>The superscription directs the registered pharmacist to take the drug listed and preparethe
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
drug; the inscription lists the name and quantity of the drug being prescribed; the subscriptionprovides
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
directions to the registered pharmacist for preparing the drug; and the transcription, or signature, is the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
information the registered pharmacist writes on the label as instructions to the patient.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 7 n1
2. If generic substitution is permitted on a prescription:
n1 n1 n1 n1 n1 n1 n1
a. drug from only one manufacturer must be given.
n1 n1 n1 n1 n1 n1 n1
b. drug formulation may be changed by the registered pharmacist.
n1 n1 n1 n1 n1 n1 n1 n1
c. any manufactured brand of the drug listed may be given.
n1 n1 n1 n1 n1 n1 n1 n1 n1
d. drug strength may be changed by the registered pharmacist.
n1 n1 n1 n1 n1 n1 n1 n1
PRECISE ANSWER:-C n1
Reasoning :->>>A generic substitution allows any brand of a drug to be given, but the registered
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
pharmacist may not change a drug formulation without specific permission from the prescribing physician.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
A physician can indicate to the registered pharmacist that generic substitution is permitted in the filling of
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
the prescription. In such a case, the registered pharmacist may provide any manufacturer’s version of the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
prescribed drug, rather than a specific brand. However, the registered pharmacist may not change
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
thestrength of a drug without specific permission from the prescribing physician.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 8 n1
3. The study of drug, including their origin, properties, and interactions with living organisms, is known as
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
PRECISE ANSWER:-B n1
Reasoning:->>>Pharmacogenetics is the study of the interrelationship of genetic differences and drug effects. n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
Pharmacology is the study of drug (chemicals), including their origin, properties, and interactionswith living
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
organisms.
n1
Therapeutics is the art of treating illness with drug. Toxicology is the study of toxic substances and
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
theirpharmacologic actions, including antidotes and poison control.
n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 3 n1
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. chemical name. n1
b. generic name. c.official name. d.trade name. n1 n1 n1 n1 n1
PRECISE ANSWER:-D n1
Reasoning:->>>The chemical name indicates the drug’s chemical structure. The generic name is assignedby the n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
, United States
n1 n1
, Adopted Name Council and is usually based loosely on the drug’s chemical structure. The official name isthe
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
name given to the generic name once a drug becomes fully approved for general use and is admitted to the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
United States Pharmacopeia–National Formulary. The trade name is the brand, or proprietary, name given
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
by a particular manufacturer. For example, the generic drug albuterol is currently marketed by Schering-
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
n1 n1 n1
n1
n1 n1 n1 n1
REFERENCE: n 1 p. 5 n1
5. To find official information about drug (according to the FDA), you need to go to the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. Physician’s Desk Referenceerence (PDR). n1 n1 n1
b. Basic & Clinical Pharmacology. n1 n1 n1
c. United States Pharmacopeia–National Formulary (USP-NF).
n1 n1 n1 n1
d. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. n1 n1 n1 n1 n1 n1 n1
PRECISE ANSWER:-C n1
Reasoning:->>>Because the PDR is prepared by drug manufacturers themselves, it may be lacking in n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
objectivity. Basic & Clinical Pharmacology covers only general pharmacologic principles and drug classes.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
Goodman & Gilman’s The Pharmacological Basis of Therapeutics covers only general
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
pharmacologicprinciples and drug classes. The USP-NF is a book of standards containing information
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
about drugs, dietary supplements, and medical devices. The U.S. Food and Drug Administration
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
(FDA)considers this book the official standard for drug marketed in the United States.
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
REFERENCE: n 1 p. 5 n1
6. Drug may be obtained from which of the following sources?
n1 n1 n1 n1 n1 n1 n1 n1 n1
a. Plants
b. Animals
c. Minerals
d. Plants, animals, and minerals n1 n1 n1
PRECISE ANSWER:-D n1
Reasoning:->>>Drug may be obtained from plants (e.g., digitalis), animals (e.g., insulin), and minerals(e.g., n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
magnesium sulfate).
n1 n1
REFERENCE: n 1 p. 5 n1
7. The branch of the U.S. government responsible for the process of approving drug for clinical use is the
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
a. USAN Council. n1
b. FDA.
c. USP-NF.
d. PDR.
PRECISE ANSWER:-B n1
Reasoning:->>>The United States Adopted Name (USAN) Council is responsible for assigning a generic n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
name to a chemical that appears to have therapeutic use. The U.S. Food and Drug Administration (FDA) is
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
responsible for the process of approving drug for clinical use. The process by which a chemical movesfrom
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
the status of a promising potential drug to one fully approved by the FDA for general clinical use is,on
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
average, long, costly, and complex. Cost estimates vary, but in the 1980s it took an average of 13 to 15
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
yearsfrom chemical synthesis to marketing approval by the FDA, with a cost of $350 million in the United
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
States.
n1
The USP-NF is a book
n1 n1 n1 n1
of standards for drugs, dietary supplements, and medical devices. The PDR is a source of druginformation
n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1 n1
prepared by drug manufacturers.
n1 n1 n1 n1
REFERENCE: n 1 p. 4 n1
